References
- Manadan AM, Sequeira W, Block JA. 2006; The treatment of psoriatic arthritis. Am J Ther. 13:72–9.
- Spring 2005 Survey Panel Snapshot. National Psoriasis Foundation. Accessed 18 November 2005. URL: http://www.psoriasis.org/research/foundation/survey_panels.php
- Gladman DD, Shuckett R, Russell ML, Thorne JC, Schachter RK. 1987; Psoriatic arthritis (PSA) – an analysis of 220 patients. QJ Med. 62:127–41.
- Rapp SR, Feldman SR, Exum ML, Fleischer AB Jr, Reboussin DM. 1999; Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol. 41:(3 Pt 1)401–7.
- Mease PJ, Kivitz AJ, Burch FX, Siegel EL, Cohen SB, Ory P, 2004; Etanercept treatment of psoriatic arthritis: Safety, efficacy, and effect on disease progression. Arthritis Rheum. 50:2264–72.
- Helliwell PS. 2007; GRAPPA – Group for Research and Assessment of Psoriasis and Psoriatic Arthritis, Stockholm, May/June 2006. J Rheumatol. 34:214–19.
- Doherty M, Dacre J, Dieppe P, Snaith M. 1992; The ‘GALS’ locomotor screen. Ann Rheum Dis. 51:1165–9.